novo nordisk glp-1 medications plans to slash prices Oral GLP-1 Wegovy chases approval

Marchetti P, Lupi R, Bugliani M, Kirkpatrick CL, Sebastiani G, Grieco FA, Del Guerra S, D'Aleo V, Piro S, Marselli L, Boggi U, Filipponi F, Tinti L, Salvini L, Wollheim CB, Purrello F, Dotta F

As we step into a new, more accessible era of anti-obesity care, contributing to a sharper demand for GLP-1s and similar medications, its important that patients, providers and employers understand the key differences between formulations and how they impact health outcomes

The primary issue is that meds are replacing exercise and diet, resulting in more muscle loss, argues one rheumatology and internal medicine physician on Sermo

The most common early side effects of semaglutide, tirzepatide, or retatrutide include: Nausea or bloating Constipation Fatigue or low energy Mild dehydration Each of these symptoms can make physical intimacy less appealing

Lipids potently increase CCK release 180,181 , and administration of CCK-1R antagonists blocks the satiating effects of intestinal lipid infusion in both rodents and humans 169,182